News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. 10-year Treasury yield nears 5%, pressuring equities and raising corporate borrowing costs.
  • Goldman Sachs turns tactically neutral, citing rising yields and near-term inflation prints as key market risks.
  • Japan's yen jumped ahead of a likely BOJ rate hike, triggering FX volatility and Asian market repositioning.
  • Zelenskiy said U.S. envoys proposed ideas but achieved no breakthrough, maintaining geopolitical uncertainty before planned U.S. talks.
  • Biotech volatility rose: Ionis failed a Phase 3, Biohaven was downgraded, while Roivant and Pharvaris reported positive trial results.
  • India's Nifty closed at a one-month low as FMCG, healthcare and oil & gas stocks weighed on market breadth.

Latest Articles

Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments

Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments

Beyond Air, Inc. has entered into an agreement to sell its 58% stake in NeuroNOS Israel Ltd., a biopharmaceutical company focused on neurological disorders, to UNIVO Pharmaceutical Industries Ltd. In exchange, Beyond Air will receive 19.99% ownership in UNIVO, warrants, and milestone payments up to $32.5 million tied to NeuroNOS's development and c…

Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial of Denifanstat in Acne Toward Patient Enrollment in Q4 2026

Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial of Denifanstat in Acne Toward Patient Enrollment in Q4 2026

Sagimet Biosciences announced that its AURORA Phase 3 clinical trial for denifanstat, a novel oral FASN inhibitor for moderate to severe acne, is on track to begin patient enrollment in Q4 2026. The trial plans to enroll approximately 800 U.S. patients, including 450 adolescents, to evaluate both efficacy and long-term safety. Positive prior result…

Immatics Announces $150 Million Underwritten Offering

Immatics Announces $150 Million Underwritten Offering

Immatics N.V., a clinical-stage biopharmaceutical company focused on precision targeting of PRAME in cancer therapies, announced a $150 million underwritten offering of ordinary shares and pre-funded warrants. The proceeds will support its clinical programs involving TCR T-cell therapies and bispecifics. The offering is expected to close by August …

Lotus Tech Completed Acquisition of 100% Equity Interest of Lotus Advance Technologies, Integrating All Businesses and Operations Under One Lotus

Lotus Tech Completed Acquisition of 100% Equity Interest of Lotus Advance Technologies, Integrating All Businesses and Operations Under One Lotus

Lotus Technology Inc. has finalized the acquisition of 100% equity in Lotus Advance Technologies (Lotus UK), integrating the iconic British sports car engineering and manufacturing operations into a single global business. This consolidation is expected to drive synergies in R&D, supply chain, manufacturing, and global sales, accelerating Lotus's F…

Canada-Japan Funding Fuels Xanadu and Mitsubishi Chemical Partnership on Quantum Semiconductor Research

Canada-Japan Funding Fuels Xanadu and Mitsubishi Chemical Partnership on Quantum Semiconductor Research

Xanadu Quantum Technologies and Mitsubishi Chemical are entering the next phase of their collaboration to enhance semiconductor manufacturing via quantum computing, specifically targeting extreme ultraviolet (EUV) lithography. Supported by Canadian and Japanese government innovation programs, this partnership aims to develop fault-tolerant quantum …

Fury Reports Infill Drill Results; Returns High Grade at Eau Claire Including 14.41 g/t over 3.92 Metres

Fury Reports Infill Drill Results; Returns High Grade at Eau Claire Including 14.41 g/t over 3.92 Metres

Fury Gold Mines Limited announced strong assay results from its Phase 2 infill drilling program at the Eau Claire Gold Project, confirming high-grade gold mineralization and continuity in inferred resource zones. The results advance their objective of converting inferred resources into higher-confidence categories ahead of a planned pre-feasibility…

Targa Resources Corp. Announces Addition of Experienced Industry Executive and Leadership Changes to Support Continued Long-Term Growth

Targa Resources Corp. Announces Addition of Experienced Industry Executive and Leadership Changes to Support Continued Long-Term Growth

Targa Resources Corp. announced leadership changes including hiring Brent B. Secrest as President - Logistics and Transportation, and appointing Benjamin J. Branstetter as Chief Financial Officer, while current CFO William A. Byers plans retirement with transition support through end of 2026. These executive moves aim to support Targa's long-term g…

Willis Lease Finance Corporation Closes Transaction to Acquire Commercial Aircraft and Aircraft Engine Portfolio

Willis Lease Finance Corporation Closes Transaction to Acquire Commercial Aircraft and Aircraft Engine Portfolio

Willis Lease Finance Corporation has successfully closed a deal to acquire 12 commercial aircraft and 13 aircraft engines, enhancing its portfolio in aircraft and engine leasing. This acquisition is part of the company's strategy to leverage its integrated leasing, asset management, technical, and aftermarket capabilities to maximize asset utilizat…

Akamai Announces Strategic Alliance with Deloitte Canada to Help Organizations Achieve Platform-Based Resilience Against AI-Accelerated Cyberthreats

Akamai Announces Strategic Alliance with Deloitte Canada to Help Organizations Achieve Platform-Based Resilience Against AI-Accelerated Cyberthreats

Akamai Technologies announced a strategic alliance with Deloitte Canada aimed at delivering platform-based cyber resilience to combat the rapid escalation of AI-accelerated cyber threats. This partnership integrates Deloitte's cybersecurity advisory and managed services with Akamai's advanced security technologies to help organizations modernize an…

Nayax Enters into Definitive Agreement to Acquire IPS Group, a Leading Smart Parking Technology Provider

Nayax Enters into Definitive Agreement to Acquire IPS Group, a Leading Smart Parking Technology Provider

Nayax Ltd., a global payments and commerce platform, announced a definitive agreement to acquire IPS Group, a smart parking technology provider, in an all-cash transaction valued at $350 million. The acquisition aims to integrate IPS's smart parking hardware and software with Nayax's payments infrastructure, expanding into new markets such as Conti…

Canadian Consumer Debt Reaches Record $2.64 Trillion as Financial Realities Differ Across Households

Canadian Consumer Debt Reaches Record $2.64 Trillion as Financial Realities Differ Across Households

TransUnion's Q2 2026 Credit Industry Insights Report reveals Canadian consumer debt has reached a record $2.64 trillion, with credit balance growth concentrated at the highest and lowest risk tiers. Mortgage originations slowed due to affordability pressures, while non-mortgage debt increased, notably in auto loans and personal lines of credit. Mor…

Fade the Rally in Star Bulk: Short at $31.10, Target $27.50

Fade the Rally in Star Bulk: Short at $31.10, Target $27.50

Star Bulk (SBLK) sits at a 52-week high and is trading well above its 50-day averages after what the market treated as a 'record' quarter. The fundamentals of dry-bulk are cyclical and current prices already reflect robust freight rates and a generous quarterly distribution. This trade idea proposes a tactical short - entry $31.10, stop $32.20, tar…